CRP and inflammatory bowel disease: In a previous prospective study of the SCD in pediatric IBD, Crohn’s patients with active disease had improved clinical disease activity indexes (PCDAI) with the majority of patients achieving clinical remission in conjunction with normalization/improvement in CRP and ESR over a 12-week period.